Medinice

Our projects

MiniMax

The innovative MiniMax catheter will meet the needs of outstanding cardiac surgeons and electrophysiologists, whose work, thanks to ingenious technological solutions and excellent quality of components used in the device, will become even more precise, safe and comfortable.

CoolCryo

The innovative CoolCryo catheter is addressed to the highest-class specialists-cardiac surgeons, who expect a technologically advanced device that satisfies the need to perform more effective cryoablation than available on the market, ensuring precise control of the entire cryoablation process and, which is extremely important and necessary, confirmation of the correct cryoablation already during the procedure.

PacePress

The implantation of any electrophysiological device carries the risk of serious hemorrhagic complications such as hematoma in the implantation site after implantation of cardiac stimulation devices, i.e. pacemaker or cardioverter.

EP Bioptom

EP Bioptom is an innovative electrophysiology diagnostic catheter that combines two essential functionalities: the ability to perform a three-dimensional map of the heart and the ability to perform heart tissue biopsy.

Others

Medinice S.A. is currently carrying out over a dozen projects, mainly in the area of cardiology and cardiosurgery. Each project has a high development potential and responds to a market need, identified by practitioners . Projects are at various stages of development. Four of them are currently at the early stage of patent application. These are very promising and innovative solutions used for cardiac surgery procedures.

EU Projects

Medinice S.A. carries out its projects also with co-financing from European Union Funds under the (pl. POIR) Smart Growth Operational Program and the (pl. POIG) Innovative Economy Operational Program. From the link below you will find out which projects we implement under which programs and operations, what are their goals and planned effects as well as the overall budget along with the amount of the European Union Funds grant.

About our company

Medinice S.A. since 2012, has been developing new, innovative ideas for medical products and services.

Company focuses on creating, developing and commercializing safe, minimally invasive medical technologies in the areas of cardiology and cardiosurgery. The company's mission is to increase the quality of life of patients by means of solutions applicable in modern medicine.

08 GRUDZIEŃ 2023

Patient friendly smart routing therapies for quality of life

Patient friendly smart routing therapies for quality of life

Patient friendly smart routing therapies for quality of life

Our projects

MiniMax

CoolCryo

PacePress

EP Bioptom

Others

EU Projects

About our company

News

Shareholders of Medinice S.A. appointed a new member of the Supervisory Board

Commencement of the chronic phase of the preclinical study in the MiniMax project

Medinice presents the results of research on the first of the planned two phases of chronic preclinical research in the CoolCryo project

AtriClamp project in Medinice’s product portfolio

Obtaining patent protection from the Israel Patent Office for the invention “CoolCryo”

Obtaining patent protection from the European Patent Office for the invention “CoolCryo”.

Medinice has acquired nearly PLN 25 million from the public offering of series J shares

Media o nas

Czat inwestorski 05.12.2023

Medinice chce zaktualizować harmonogram realizacji kluczowych projektów i włączyć do niego projekt AI

Przyszłość ochrony zdrowia. Firmy walczą o jak największy kawałek tortu